1,4-双-[4- [4-甲基-3-[[4-（吡啶-3-基）pyriMidin-2-yl] a氨基]苯基]氨基甲酰基]苄基哌嗪 1365802-18-1
1,4-双-[4- [4-甲基-3-[[4-（吡啶-3-基）pyriMidin-2-yl] a氨基]苯基]氨基甲酰基]苄基哌嗪 1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine 1365802-18-1
1,4-双-[4- [4-甲基-3-[[4-（吡啶-3-基）pyriMidin-2-yl] a氨基]苯基]氨基甲酰基]苄基哌嗪 1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine 1365802-18-1
1,4-双-[4- [4-甲基-3-[[4-（吡啶-3-基）pyriMidin-2-yl] a氨基]苯基]氨基甲酰基]苄基哌嗪
伊马替尼双杂质;伊马替尼二聚体杂质;IMATINIBDIMER;1,4-双-[4-[4-甲基-3-[[4-(吡啶-3-基)PYRIMIDIN-2-YL]A氨基]苯基]氨基甲酰基]苄基哌嗪;4,4'-(哌嗪-1,4-二基双(亚甲基))双(N-(4-甲基-3-((4-(吡啶-3-基)嘧啶-2-基)氨基)苯基)苯甲酰胺)(伊马替尼杂质);去(甲基哌嗪基-N-甲基)伊马替尼二聚体;马替尼杂质E
1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine
1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine;Des(Methylpiperazinyl-N-Methyl)IMatinibDiMerIMpurity;ImatinibImpurityE;ImatinibDimerImpurity;ImatinibbisImpurity;ImatinibImp.E;ImatinibImpurityE/Des(methylpiperazinyl-N-methyl)ImatinibDimerImpurity;Imatinibimpurity13/Des(methylpiperazinyl-N-methyl)ImatinibDimerImpurity/1,4-Bis-[4-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]carbamoyl]benzylpiperazine
1365802-18-1
C52H48N12O2
873.02
1.327±0.06 g/cm3(Predicted)
>213°C (dec.)
二甲基亚砜（微溶）
Refrigerator
生物活性 ImatinibImpurityE是Imatinib的杂质。Imatinib是一种口服生物可用的酪氨酸激酶抑制剂，可选择性抑制BCR/ABL，v-Abl，PDGFR，c-kit激酶活性。Imatinib(STI571)靠近ATP结合位点结合，将其锁定在封闭或自我抑制的构象中，因此半竞争性抑制蛋白质的酶活性。Imatinib还抑制SARS-CoV和MERS-CoV。
